Abstract:Background: This study uses a novel geographic approach to summarize the distribution of breast cancer in San Francisco and aims to identify the neighborhoods and racial/ethnic groups that are disproportionately affected by this disease.Methods: Nine geographic groupings were newly defined based on racial/ethnic composition and neighborhood socioeconomic status. Distribution of breast cancer cases from the Greater Bay Area Cancer Registry in these zones were examined. Multivariable logistic regression models w… Show more
“…TNBC, one of the most aggressive forms of breast cancer, has limited treatment options that are ineffective when the cancer is diagnosed at later stages [25][26][27][28][29]. Since AA women tend to be diagnosed at later stages [30,31], at an early age [32][33][34], and suffer higher rates of TNBC, these factors likely contribute to AAs having the highest breast cancer mortality rate among all race groups.…”
Triple negative breast cancers (TNBCs) are molecularly heterogeneous, and the link between their aggressiveness with African ancestry is not established. We investigated primary TNBCs for gene expression among self-reported race (SRR) groups of African American (AA, n = 42) and European American (EA, n = 33) women. RNA sequencing data were analyzed to measure changes in genome-wide expression, and we utilized logistic regressions to identify ancestry-associated gene expression signatures. Using SNVs identified from our RNA sequencing data, global ancestry was estimated. We identified 156 African ancestry-associated genes and found that, compared to SRR, quantitative genetic analysis was a more robust method to identify racial/ethnic-specific genes that were differentially expressed. A subset of African ancestry-specific genes that were upregulated in TNBCs of our AA patients were validated in TCGA data. In AA patients, there was a higher incidence of basal-like two tumors and altered TP53, NFB1, and AKT pathways. The distinct distribution of TNBC subtypes and altered oncologic pathways show that the ethnic variations in TNBCs are driven by shared genetic ancestry. Thus, to appreciate the molecular diversity of TNBCs, tumors from patients of various ancestral origins should be evaluated.
“…TNBC, one of the most aggressive forms of breast cancer, has limited treatment options that are ineffective when the cancer is diagnosed at later stages [25][26][27][28][29]. Since AA women tend to be diagnosed at later stages [30,31], at an early age [32][33][34], and suffer higher rates of TNBC, these factors likely contribute to AAs having the highest breast cancer mortality rate among all race groups.…”
Triple negative breast cancers (TNBCs) are molecularly heterogeneous, and the link between their aggressiveness with African ancestry is not established. We investigated primary TNBCs for gene expression among self-reported race (SRR) groups of African American (AA, n = 42) and European American (EA, n = 33) women. RNA sequencing data were analyzed to measure changes in genome-wide expression, and we utilized logistic regressions to identify ancestry-associated gene expression signatures. Using SNVs identified from our RNA sequencing data, global ancestry was estimated. We identified 156 African ancestry-associated genes and found that, compared to SRR, quantitative genetic analysis was a more robust method to identify racial/ethnic-specific genes that were differentially expressed. A subset of African ancestry-specific genes that were upregulated in TNBCs of our AA patients were validated in TCGA data. In AA patients, there was a higher incidence of basal-like two tumors and altered TP53, NFB1, and AKT pathways. The distinct distribution of TNBC subtypes and altered oncologic pathways show that the ethnic variations in TNBCs are driven by shared genetic ancestry. Thus, to appreciate the molecular diversity of TNBCs, tumors from patients of various ancestral origins should be evaluated.
“…Furthermore, the majority of studies did not consider the geographic distribution of the disease to account for the possibility that nearby neighborhoods are more likely to be similar to one another. Recent geospatial cluster analyses show some nSES measures may be more effective than others at explaining the geospatial distribution of cancer within a particular state, 10 and that differences in nSES by neighborhood or geographic location, including living in an urban versus rural area, 101 could affect cancer mortality 102 . This suggests additional studies that consider spatial associations, urbanicity, and evaluate more than one existing nSES index are warranted before particular nSES measures can be recommended as a standard (Table 3).…”
Section: Discussionmentioning
confidence: 99%
“…Fourth, the majority of studies reviewed were conducted in California, a national leader in the evaluation of nSES and cancer outcomes which can serve as a model for other states 126 . However, in order to move towards standardized nSES index measures, studies across more US states are needed, given that the variation in nSES indices and their associated variables likely differ by geography 102 . Fifth, the majority of reviewed studies utilized State Cancer Registries.…”
Section: Discussionmentioning
confidence: 99%
“…126 However, in order to move towards standardized nSES index measures, studies across more US states are needed, given that the variation in nSES indices and their associated variables likely differ by geography. 102 Fifth, the majority of reviewed studies utilized State Cancer Registries. Increasing the number of state-specific analyses within and across cancer sites could help clarify the role of nSES in cancer outcomes.…”
Section: Limitations and Additional Recommendations For Future Studiesmentioning
Background
There is extensive interest in understanding how neighborhood socioeconomic status (nSES) may affect cancer incidence or survival. However, variability regarding items included and approaches used to form a composite nSES index presents challenges in summarizing overall associations with cancer. Given recent calls for standardized measures of neighborhood sociodemographic effects in cancer disparity research, the objective of this systematic review was to identify and compare existing nSES indices studied across the cancer continuum (incidence, screening, diagnosis, treatment, survival/mortality) and summarize associations by race/ethnicity and cancer site to inform future cancer disparity studies.
Methods
Using PRISMA guidelines, peerâreviewed articles published between 2010 and 2019 containing keywords related to nSES and cancer were identified in PubMed.
Results
Twentyâfour nSES indices were identified from 75 studies. In general, findings indicated a significant association between nSES and cancer outcomes (n = 64/75 studies; 85.33%), with 42/64 (65.63%) adjusting for highlyâcorrelated individual SES factors (e.g., education). However, the direction of association differed by cancer site, race/ethnicity, and nSES index.
Conclusions
This review highlights several methodologic and conceptual issues surrounding nSES measurement and potential associations with cancer disparities. Recommendations pertaining to the selection of nSES measures are provided, which may help inform disparityârelated disease processes and improve the identification of vulnerable populations in need of intervention.
“…That system has been developed by a team led by Scarlett Lin Gomez, PhD, MPH, a professor of epidemiology and biostatistics at the University of California at San Francisco. One of her recent studies found that patients living in San Francisco neighborhoods with a lower socioeconomic status and larger minority populations had worse outcomes for breast cancer . The study revealed both neighborhoodâlevel and racial/ethnic differences in the stage of diagnosis, the molecular subtype of the tumor, survival, and mortality.…”
Section: Multilayer Impacts On Cancer Outcomesmentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citationsâcitations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.